Bharati R Dhruva

Array ( [id] => 243337 [patent_doc_number] => 07589071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-15 [patent_title] => 'Large capacity viral amplicon using a minimal orilyt from human cytomegalovirus' [patent_app_type] => utility [patent_app_number] => 10/178049 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13792 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589071.pdf [firstpage_image] =>[orig_patent_app_number] => 10178049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800788 [patent_doc_number] => 20030095952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Multi-organ engraftment with a single bone marrow-derived stem cell' [patent_app_type] => new [patent_app_number] => 10/165533 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11884 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095952.pdf [firstpage_image] =>[orig_patent_app_number] => 10165533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678121 [patent_doc_number] => 20030228261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue' [patent_app_type] => new [patent_app_number] => 10/163763 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5566 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228261.pdf [firstpage_image] =>[orig_patent_app_number] => 10163763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867464 [patent_doc_number] => 07364725 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-29 [patent_title] => 'Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor' [patent_app_type] => utility [patent_app_number] => 10/163387 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 15338 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364725.pdf [firstpage_image] =>[orig_patent_app_number] => 10163387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 529389 [patent_doc_number] => 07175658 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-13 [patent_title] => 'Artificial vascular grafts, their construction and use' [patent_app_type] => utility [patent_app_number] => 10/164219 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 15854 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/175/07175658.pdf [firstpage_image] =>[orig_patent_app_number] => 10164219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687925 [patent_doc_number] => 20030031650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Drug inducible system and use thereof' [patent_app_type] => new [patent_app_number] => 10/161333 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8481 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031650.pdf [firstpage_image] =>[orig_patent_app_number] => 10161333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74294 [patent_doc_number] => 07749973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Methods of gene transfer to astrocytes with mokola virus pseudotyped lentivirus vectors' [patent_app_type] => utility [patent_app_number] => 10/477375 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5005 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749973.pdf [firstpage_image] =>[orig_patent_app_number] => 10477375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985684 [patent_doc_number] => 06924415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Transgenic mice comprising a constitutively-activated MEK5 and exhibiting cardiac hypertrophy and dilated cardiomyopathy' [patent_app_type] => utility [patent_app_number] => 10/159971 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30953 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924415.pdf [firstpage_image] =>[orig_patent_app_number] => 10159971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736039 [patent_doc_number] => 20030013674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Use of targeted cross-linked nanoparticles for in vivo gene delivery' [patent_app_type] => new [patent_app_number] => 10/159241 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10505 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013674.pdf [firstpage_image] =>[orig_patent_app_number] => 10159241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809149 [patent_doc_number] => 20030199088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Minicell-based gene therapy' [patent_app_type] => new [patent_app_number] => 10/156902 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 143627 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199088.pdf [firstpage_image] =>[orig_patent_app_number] => 10156902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656568 [patent_doc_number] => 20030009775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Mouse model for hepatitis C' [patent_app_type] => new [patent_app_number] => 10/157099 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5016 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009775.pdf [firstpage_image] =>[orig_patent_app_number] => 10157099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725521 [patent_doc_number] => 20030207833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Pharmaceutical compositions with minicells' [patent_app_type] => new [patent_app_number] => 10/156811 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 143490 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207833.pdf [firstpage_image] =>[orig_patent_app_number] => 10156811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7143641 [patent_doc_number] => 20050118566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins' [patent_app_type] => utility [patent_app_number] => 10/478434 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13274 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118566.pdf [firstpage_image] =>[orig_patent_app_number] => 10478434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654042 [patent_doc_number] => 20030077251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins' [patent_app_type] => new [patent_app_number] => 10/152040 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15527 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077251.pdf [firstpage_image] =>[orig_patent_app_number] => 10152040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529149 [patent_doc_number] => 20020192821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/154452 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21811 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192821.pdf [firstpage_image] =>[orig_patent_app_number] => 10154452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814043 [patent_doc_number] => 20060084139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 10/152370 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 58867 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084139.pdf [firstpage_image] =>[orig_patent_app_number] => 10152370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874471 [patent_doc_number] => 20030194768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/152371 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63478 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194768.pdf [firstpage_image] =>[orig_patent_app_number] => 10152371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7215826 [patent_doc_number] => 20050054591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Yin yang-1' [patent_app_type] => utility [patent_app_number] => 10/478488 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17292 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054591.pdf [firstpage_image] =>[orig_patent_app_number] => 10478488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117161 [patent_doc_number] => 20050070462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Method for stabilising of nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/478426 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4547 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070462.pdf [firstpage_image] =>[orig_patent_app_number] => 10478426 [rel_patent_id] =>[rel_patent_doc_number] =>)